| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 6 |
| 1 | VENETOCLAX | 6 |
| 2 | HYDROXYUREA | 5 |
| 3 | NILOTINIB | 5 |
| 4 | PONATINIB HYDROCHLORIDE | 5 |
| 5 | RITUXIMAB | 5 |
| 6 | BOSUTINIB | 4 |
| 7 | CHLORAMBUCIL | 4 |
| 8 | CYCLOPHOSPHAMIDE | 4 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORAMBUCIL | 4 | 0.0010 |
| 1 | PONATINIB HYDROCHLORIDE | 5 | 0.0010 |
| 2 | AFATINIB | 3 | 0.0005 |
| 3 | BOSUTINIB | 4 | 0.0004 |
| 4 | DASATINIB | 4 | 0.0004 |
| 5 | GEFITINIB | 3 | 0.0003 |
| 6 | HYDROXYUREA | 5 | 0.0002 |
| 7 | NILOTINIB | 5 | 0.0002 |
| 8 | FLUDARABINE PHOSPHATE | 4 | 0.0001 |
| 9 | VENETOCLAX | 6 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 17 |
| 1 | BCL-2 Inhibitor [EPC] | 6 |
| 2 | Antimetabolite [EPC] | 5 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 5 |
| 4 | Corticosteroid [EPC] | 5 |
| 5 | Alkylating Drug [EPC] | 4 |
| 6 | Janus Kinase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Kinase Inhibitor [EPC] | 17 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 4 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 5 | 0.0000 |